欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2014, Vol. 19 ›› Issue (5): 538-541.

• 基础研究 • 上一篇    下一篇

5-氟尿嘧啶联合蒽贝素治疗结肠癌的研究

蒋正财, 叶兵, 周磊   

  1. 温州医科大学附属第二医院肿瘤外科,温州 325000,浙江
  • 收稿日期:2013-09-23 修回日期:2014-04-21 出版日期:2014-05-26 发布日期:2014-06-05
  • 作者简介:蒋正财,男,硕士,主治医师,从事胃肠肿瘤基础及临床研究工作。Tel: 18672362495 E-mail: 527236911@qq.com
  • 基金资助:
    温州市科技计划项目(201350387)

Effects of 5-FU combined with embelin for the treatment of colorectal cancer

JIANG Zheng-cai, YE Bing, ZHOU Lei   

  1. The Second Hospital Affiliated to Wenzhou Medical University,Wenzhou 325000,Zhejiang,China
  • Received:2013-09-23 Revised:2014-04-21 Online:2014-05-26 Published:2014-06-05

摘要: 目的:探讨5-氟尿嘧啶(5-FU)联合蒽贝素对结肠癌的治疗作用。方法:MTT法和肿瘤球生长实验考察5-FU联合蒽贝素对结肠癌C26细胞的毒性。建立结肠癌小鼠移植瘤模型,随机分为生理盐水组、5-FU组、蒽贝素组和联合给药组。各组小鼠均 3 d 一次尾静脉注射给药。观察给药过程中瘤体体积的变化,考察不同给药组对小鼠肿瘤生长的抑制效果。结果:给药 48 h 后生理盐水组肿瘤细胞存活率为95%,5-FU组、蒽贝素组和联合给药组肿瘤细胞存活率分别为48%、69%和18%,与单独给药组相比,联合给药能够显著增强对C26细胞的增殖抑制作用(P<0.01)。给药 7 d 后,生理盐水组肿瘤球持续生长,体积增大 1.52 倍,3个给药组肿瘤球体积出现了不同程度的减小,5-FU组、蒽贝素组和联合给药组分别使肿瘤体积减小到原体积的71%、89%和33%(P<0.01);生理盐水组、蒽贝素组、5-FU小鼠肿瘤体积成长分别变为给药前肿瘤体积的 1.85 倍、1.79 倍和 1.49 倍,而联合给药组为 1.21 倍(P<0.01)。联合给药组与蒽贝素组和5-FU组单独给药组间差异具有统计学意义(P<0.01)。同时联合给药能够延长荷瘤小鼠的中位生存期。结论:5-FU与蒽贝素都具有抗结肠癌作用,且二者联合使用效果更显著。

关键词: 结肠癌, 5-氟尿嘧啶, 蒽贝素, 联合

Abstract: AIM: To evaluate the effect of 5-FU combined with embelin on the treatment of colorectal cancer.METHODS: The anti-proliferation efficiency of 5-FU combined with embelin was evaluated by MTT assay and colony-forming assay. C26 cells were xenografted in mice to establish the animal model, which were used to evaluate the effect of anti-tumor. The tumor size sere measured every group. HE were used to observe the apoptosis of cancer cells.RESULTS: Both 5-FU and embelin could inhibit the growth of C26 cells compare to saline. The cell viability of C26 cells were 95%, 48%, 69% and 18% after the treatment of saline, 5-FU, embelin and 5-FU+embelin, respectively (P<0.01). Tumor spheroids continued to grow in size and volume in saline 152% of the primary volume. The change ratios of tumor spheroid volumes (%) were nearly 71%, 89% and 33% for 5-FU, embelin and 5-FU+embelin, respectively (P<0.01). The inhibition of colorectal cancer in vivo demonstrated the change ratios of tumor volumes (%) were nearly 179%, 149% and 121% for 5-FU, embelin and 5-FU+embelin, while the saline group was 185%, respectively (P<0.01).CONCLUSION: The 5-FU and embelin can inhibit the growth of colorectal cancer, and the combination of 5-FU and embelin may be a potentially effective treatment for colorectal cancer.

Key words: colorectal cancer, 5-FU, embelin, combination

中图分类号: